Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.
In these podcasts, we dive deep into the world of rare diseases, where every story is unique and every diagnosis a challenge. The episodes highlight the personal journeys of patients and medical professionals as they navigate the complexities of rare conditions. Each episode features expert insights on cutting-edge research, emerging treatments, and the social and emotional aspects of living with a rare disease. These podcasts are your guide to understanding and advocating for those affected by these often misunderstood conditions.
| Episode | Date |
|---|---|
|
Episode 33 - Advanced Therapies and the Future of Uncontrolled Gout
|
Jun 12, 2026 |
|
Episode 32 - Optimizing Gout Care Across the Disease Continuum
|
Jun 12, 2026 |
|
Episode 31 - Beyond the Joint: The Burden and Biology of Uncontrolled Gout
|
Jun 12, 2026 |
|
Episode 30 - Days 3 and 4: Key Breakthroughs from EASL 2026
|
Jun 03, 2026 |
|
Episode 29 - Days 1 and 2: Key Breakthroughs from EASL 2026
|
Jun 03, 2026 |
|
Episode 28 - NF1-PN Podcast: Key Advances from AAN 2026
|
Apr 24, 2026 |
|
Episode 27 - MG Podcast: Emerging Insights from AAN 2026
|
Apr 23, 2026 |
|
Episode 26 - Patient-Focused Strategies to Effectively Diagnose, Treat, and Manage NF1-PN
|
Oct 16, 2025 |
|
Episode 25 - Recent Progress in NF1-PN: Pathophysiology, Role of MEK Inhibitors, Recognizing the NF1-PN Patient
|
Oct 06, 2025 |
|
Episode 24 - Precision in Practice: Elevating Care for Uncontrolled Gout
|
Sep 23, 2025 |
|
Episode 23 - Rethinking Stroke Prevention: Addressing the Unmet Needs in Antithrombotic Therapy - Part 7 - The Future of Stroke Prevention - What's Next?
|
Aug 25, 2025 |
|
Episode 22 - Rethinking Stroke Prevention: Addressing the Unmet Needs in Antithrombotic Therapy - Part 6 - Case Study Challenge - Applying Knowledge to Patient Care
|
Aug 25, 2025 |
|
Episode 21 - Rethinking Stroke Prevention: Addressing the Unmet Needs in Antithrombotic Therapy - Part 5 - Practical Considerations - How Will FXIa Inhibitors Fit Into Stroke Prevention?
|
Aug 25, 2025 |
|
Episode 20 - Rethinking Stroke Prevention: Addressing the Unmet Needs in Antithrombotic Therapy - Part 4 - Clinical Data Deep Dive - What Clinical Trials Tell Us
|
Aug 25, 2025 |
|
Episode 19 - Rethinking Stroke Prevention: Addressing the Unmet Needs in Antithrombotic Therapy - Part 3 - Understanding Residual Stroke Risk and the Consequences of Undertreatment
|
Aug 25, 2025 |
|
Episode 18 - Rethinking Stroke Prevention: Addressing the Unmet Needs in Antithrombotic Therapy - Part 2 - FXIa Inhibition - A New Paradigm in Stroke Prevention
|
Aug 25, 2025 |
|
Episode 17 - Rethinking Stroke Prevention: Addressing the Unmet Needs in Antithrombotic Therapy - Part 1 - The Unmet Needs in Stroke Prevention
|
Aug 25, 2025 |
|
Episode 16 - Neurofibromatosis Type 1-related Plexiform Neurofibromas: Key Advances from the 2025 Annual Oncology Conference (Chicago)
|
Jun 05, 2025 |
|
Episode 15 - Clinical Clips from EASL Congress 2025: Key Breakthroughs in the Treatment of Primary Biliary Cholangitis - Part 2
|
May 13, 2025 |
|
Episode 14 - Clinical Clips from EASL Congress 2025: Key Breakthroughs in the Treatment of Primary Biliary Cholangitis - Part 1
|
May 13, 2025 |
|
Episode 13 - Emerging Evidence in Myasthenia Gravis: Key Updates from AAN 2025
|
Apr 30, 2025 |
|
Episode 12 - Emerging Evidence in Myasthenia Gravis: A Special Edition Podcast Series - Part 4 The Future of MG Care: Innovations in Diagnostics and Guidelines
|
Apr 28, 2025 |
|
Episode 11 - Emerging Evidence in Myasthenia Gravis: A Special Edition Podcast Series - Part 3 Tailoring Treatment: The Role of Serotype Testing
|
Apr 24, 2025 |
|
Episode 10 - Emerging Evidence in Myasthenia Gravis: A Special Edition Podcast Series - Part 2 Innovations in MG Therapeutics
|
Apr 21, 2025 |
|
Episode 9 - Emerging Evidence in Myasthenia Gravis: A Special Edition Podcast Series - Part 1 Advancements in Myasthenia Gravis Diagnosis
|
Apr 17, 2025 |
|
Episode 8 - Integrating Practice-Changing Updates to Improve Outcomes Among Patients
|
Jan 21, 2025 |
|
Episode 7 - Clinical Clips® from AASLD 2024: Key Breakthroughs in the Treatment of Primary Biliary Cholangitis - Part 2
|
Jan 21, 2025 |
|
Episode 6- Clinical Clips® from AASLD 2024: Key Breakthroughs in the Treatment of Primary Biliary Cholangitis - Part 1
|
Jan 20, 2025 |
|
Episode 5 - Patient Voices in Primary Biliary Cholangitis: A CE Podcast Series to Recognize Challenges, Reduce Disparities, and Improve Outcomes - Part 3: Woman with PBC Requiring 2nd-Line Therapy
|
Jan 20, 2025 |
|
Episode 4 - Patient Voices in Primary Biliary Cholangitis: A CE Podcast Series to Recognize Challenges, Reduce Disparities, and Improve Outcomes - Part 2: Comorbidities and PBC
|
Jan 20, 2025 |
|
Episode 3 - Patient Voices in Primary Biliary Cholangitis: A CE Podcast Series to Recognize Challenges, Reduce Disparities, and Improve Outcomes - Part 1: Long-Standing PBC
|
Jan 20, 2025 |
|
Episode 2 - Podcast from EASL Congress 2024: Key Breakthroughs in the Treatment of Primary Biliary Cholangitis - Part 2
|
Jan 20, 2025 |
|
Episode 1 -Podcast from EASL Congress 2024: Key Breakthroughs in the Treatment of Primary Biliary Cholangitis - Part 1
|
Jan 20, 2025 |